Skip to content. | Skip to navigation

Sections
IMPaCT Trial

Individualised Molecular Pancreatic Cancer Therapy (IMPaCT) is a new clinical trial looking at individualising the treatment of patients with metastatic pancreatic cancer.

Make a Donation

Help the APGI and ensure our work continues. Make a donation today.

Get Email Updates
Familial Cancer Cohort

If you would like to be involved in the project please click here to find out more.

 

APGI News

Parliament House Event

MPs and Senators marked the conclusion of Pancreatic Cancer Awareness Month with an Awareness barbecue hosted by Hon Malcolm Turnbull. Professor Andrew Biankin showcased the APGI's recent research findings and the impact this will have on cancer treatment.

Read More

Inaugural Pancreatic Cancer Forum Success

The inaugural Pancreatic Cancer Forum was the first of its kind in Australia, bringing together researchers, clinicians and families affected by pancreatic cancer.

Read More

Team Phil's Melbourne Marathon Success

Team Phil's effort in the Melbourne Marathon has now raised over $100, 000 for APGI's pancreatic cancer research! This year even more Team Phil members competed to beat pancreatic cancer, raising funds and awareness for this devastating disease.

Read More

Unmasking the Deadly Secrets of Pancreatic Cancer

"Pancreatic cancer is not one disease, but many, and suggests that people who seemingly have the same cancer might need to be treated differently" said Professor Andrew Biankin as he discussed the APGI's findings published in Nature. This is set to change the face of treatment, moving towards the vision of personalised medicine which matches the right treatment to the right individual.

Read More

APGI Researchers Recognised

Congratulations to Marina Pajic and Andreia Pinho for recently being recognised for research into pancreatic cancer.

Read More

APGI Researchers Win Award for Outstanding Cancer Research

APGI researchers at the Garvan Institute were awarded the Cancer Institute NSW Inaugural Wildfire Award 2012. This prestigious award recognises research which has had a lasting impact on the cancer field.

Read More

November: Pancreatic Cancer Awareness Month

November is International Pancreatic Cancer Awareness Month. Please join us in raising much needed awareness for this devastating disease. You can participate in one of our scheduled events, arrange your own or simply make a donation. Everything helps!

Read More

AACR Pancreatic Cancer: Progress and Challenges

The American Association for Cancer Research held a special conference on Pancreatic Cancer: Progress and Challenges, bringing together world renowned researchers in the discussion on how to diagnose and treat this devastating disease.

Read More

"Jumping gene" called sleeping beauty reveals new hope in understanding Pancreatic Cancer

The APGI contributed to this study and co-authors this Nature Publication. We’re now seeing some real movement in the field of pancreatic cancer research, and the APGI has been at the heart of much of this work.

Read More

Trek4Treatment

Blaire, Wade & Karlena will Trek4Treatment to raise awareness and much needed funding for pancreatic cancer research in memory of their father and friend, Lee Sayers.

Read More

APGI Sequencing Effort Presented at International Meeting

Sean Grimmond presents at sequencing seminar during Advances in Genome Biology and Technology Meeting.

Read More

ABC RadioNational: Life Matters Interview

Professor Andrew Biankin and Professor Sean Grimmond spoke with Life Matters host Natasha Mitchell about Genomic Research and Personalised Medicine in Pancreatic Cancer.

Read More

2nd Melbourne Avner Walk A Success

Once again there was a great turnout to help raise pancreatic cancer awareness and funds for APGI's research

Read More

APGI Symposium 2012

Scientist, health care professionals and members of the public from around Australia and the the world attended the APGI's annual Symposium on Saturday.

Read More

New Insights from Tumour Markers

There is a need to to develop biological markers (biomarkers) to better group pancreatic cancer sufferers for treatment types and for testing individual treatment strategies. A Sydney gastroenterologist, Dr Humphris who is part of the APGI research team has brought new insight to this battle with his work on CA19.9.

Read More